Leveraging the perioperative window in pancreatic cancer: lessons from the PROSPER trial
Gland Surgery · 2026-06 · 15 (6) · 152-152
DOI: 10.21037/gs-2026-0166 ↗Kurz gefasst
Editorial in der Zeitschrift Gland Surgery, 2026-06. Verfasst von Forrest Bethel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Miami Miller School of Medicine & Sylvester Comprehensive Cancer Center, Miami, FL, USA. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
aforementioned physiologic changes following surgery. Ricon and Ben-Eliyahu described how catecholamine and prostaglandin signaling act synergistically to suppress antitumor immunity and promote prometastatic pathways (7,8). Preclinical models demonstrate that dual inhibition attenuates surgery-induced metastatic progression (8). In this context, the PROSPER trial was designed to determine whether short-course perioperative propranolol (non-selective β -blocker) and etodolac (COX-2 inhibitor) could be safely and feasibly integrated into the perioperative window for pancreatic cancer surgery, representing one of the first randomized trials to evaluate perioperative stress modulation in patients with operable PDAC (9)
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of Miami Miller School of Medicine & Sylvester Comprehensive Cancer Center, Miami, FL, USA.
ORCID-Profile: Forrest Bethel, Andres Corona, Peter Hosein, Jashodeep Datta
Zitieren
APA
Bethel, F., Corona, A., Hosein, P., & Datta, J. (2026). Leveraging the perioperative window in pancreatic cancer: lessons from the PROSPER trial. Gland Surgery, 15(6), 152-152. https://doi.org/10.21037/gs-2026-0166
Vancouver
Bethel F, Corona A, Hosein P, Datta J. Leveraging the perioperative window in pancreatic cancer: lessons from the PROSPER trial. Gland Surgery. 2026;15(6):152-152. doi:10.21037/gs-2026-0166
BibTeX
@article{Bethel2026,
author = {Bethel, Forrest and Corona, Andres and Hosein, Peter and Datta, Jashodeep},
title = {Leveraging the perioperative window in pancreatic cancer: lessons from the PROSPER trial},
journal = {Gland Surgery},
year = {2026},
volume = {15},
number = {6},
pages = {152--152},
doi = {10.21037/gs-2026-0166}
}
EUVIMED